Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
The new website signals this pioneering, resonating role and is a tribute to the many accomplishments and innovations European TTO’s have generated and implemented over many years, thus strengthening both our economy and society.
Koenraad Debackere
KU Leuven, Belgium
ASTP brought the right structure and terminology to my knowledge of technology licensing.
René Widmer
ETH Transfer, Switzerland
Excellent professional gathering, perfect collection of topics and very up-to-date insight.
Ludovic Urgeghe
University of Mons, Belgium
Perfect balance of learning and networking.
Smiljka Vikic-Topic
University of Zagreb, Croatia
Always simply inspiring! That is ASTP.
Filip Auinger
Palacký University Olomouc, Czech Republic
Join our newsletter and get the latest news